Unknown NA INTERVENTIONAL 1-arm NCT02089490

Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery (NEVAL)

Prospective Follow-up Study for the Evaluation of the Safety and Efficacy of the Dermal Substitute NEVELIA® in the Treatment of Third-degree Burns and Reconstructive Surgery

Sponsor: Symatese

Conditions Reconstructive Surgery Third-degree Burns

Interventions NEVELIA® implantation

Updated 4 times since 2017 Last updated: Mar 14, 2014 Started: Apr 30, 2014 Primary completion: Jan 31, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02089490, this NA trial focuses on Reconstructive Surgery and Third-degree Burns and remains ongoing. Sponsored by Symatese, it has been updated 4 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jan 2017 — Jan 2021 [monthly]

Unknown Status NA

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Symatese

Data source: Symatese

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bordeaux, France